[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 249 Introduced in House (IH)]







104th CONGRESS
  1st Session
                                H. R. 249

To amend title XVIII of the Social Security Act to provide for coverage 
under part B of the medicare program of drugs approved by the Food and 
  Drug Administration for the treatment of individuals with multiple 
                               sclerosis.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 4, 1995

Mr. Greenwood introduced the following bill; which was referred to the 
 Committee on Commerce and, in addition, to the Committee on Ways and 
 Means, for a period to be subsequently determined by the Speaker, in 
   each case for consideration of such provisions as fall within the 
                jurisdication of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide for coverage 
under part B of the medicare program of drugs approved by the Food and 
  Drug Administration for the treatment of individuals with multiple 
                               sclerosis.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MEDICARE COVERAGE OF DRUGS FOR TREATMENT OF INDIVIDUALS WITH 
              MULTIPLE SCLEROSIS.

    (a) In General.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)), as amended by section 147(f)(6)(B) of the Social 
Security Act Amendments of 1994, is amended--
                    (1) by striking ``and'' at the end of subparagraph 
                (N);
                    (2) by striking ``and'' at the end of subparagraph 
                (O); and
                    (3) by inserting after subparagraph (O) the 
                following new subparagraph:
            ``(P) a drug for the treatment of individuals with multiple 
        sclerosis (if the use of the drug for such purpose is approved 
        by the Food and Drug Administration);''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to drugs furnished on or after January 1, 1996.
                                 <all>